Please note: The information displayed on this page might be outdated.
Atomwise: Operator of an artificial intelligence-based biotechnology company intended to help invent new potential medicines for more than 50 disease targets. The company's technology helps in drug hit discovery, binding affinity prediction and toxicity detection, enabling scientists to discover small molecules for the treatment and investigation of human diseases.
US - Pacific
San Francisco, CA
Company Participants at Fall Private Company Showcase 2021
- Abraham Heifets, Co-Founder & CEO